Fundz

Karyopharm Therapeutics reported raising $165 Million in an initial SEC Form D filing, from an offering of $165 Million

PUBLIC · KPTIDec 08, 2022

Amount Raised

$165 Million

$165 Million sold, per SEC Form D (first sale Dec 7, 2022)

Round Type

Venture

NewtonHealthcare

Quick answer

Karyopharm Therapeutics raised $165 Million in a funding round, dated December 7, 2022. Karyopharm Therapeutics is based in Newton, Massachusetts, United States.

How much did Karyopharm Therapeutics raise?
Karyopharm Therapeutics raised $165 Million in a funding round on December 7, 2022.
What does Karyopharm Therapeutics do?
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients..
Where is Karyopharm Therapeutics based and how big is it?
Karyopharm Therapeutics is based in Newton, Massachusetts, United States.
Who are the decision-makers at Karyopharm Therapeutics?
Fundz holds 3 contacts at Karyopharm Therapeutics, including the President and Chief Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Karyopharm Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Theravida raised $200K (Pre-Seed) on January 21, 2023.
  • ADARx Pharmaceuticals, Inc. raised $46M (Funding Round) on January 20, 2023.
  • Fort Health raised $8.8M on January 20, 2023.
  • Miach Orthopaedics raised $40M on January 20, 2023.
  • SetPoint Medical raised $65M (Debt Financing) on January 20, 2023.
  • Zorion Medical raised $2.5M (Seed) on January 20, 2023.

Who to call at Karyopharm Therapeutics, and when

A new round usually means Karyopharm Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Karyopharm Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Karyopharm Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Karyopharm Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Karyopharm Therapeutics

Location

85 WELLS AVENUE

Newton, Massachusetts, United States

About

Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. Since its founding, Karyopharm has been an industry leader in oral compounds that address nuclear export dysregulation, a fundamental mechanism of oncogenesis. Karyopharm's lead compound and first­in­class, oral exportin 1 (XPO1) inhibitor, XPOVIO® (selinexor), is approved in the U.S. and marketed by the Company in three oncology indications. It has also received regulatory approvals in various indications in a growing number of ex­U.S. territories and countries, including Europe and the United Kingdom (as NEXPOVIO®) and China. Karyopharm has a focused pipeline targeting indications in multiple high unmet need cancers, including in multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Karyopharm Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsRichard P., President and Chief Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Karyopharm Therapeutics's next move

See what Strategic adds

Karyopharm Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.